The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Olivopontocerebellar Atrophies

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Olivopontocerebellar Atrophies


Psychiatry related information on Olivopontocerebellar Atrophies


High impact information on Olivopontocerebellar Atrophies


Chemical compound and disease context of Olivopontocerebellar Atrophies


Biological context of Olivopontocerebellar Atrophies


Anatomical context of Olivopontocerebellar Atrophies


Gene context of Olivopontocerebellar Atrophies


Analytical, diagnostic and therapeutic context of Olivopontocerebellar Atrophies


  1. Presynaptic parkinsonism in olivopontocerebellar atrophy: clinical, pathological, and neurochemical evidence. Pascual, J., Pazos, A., del Olmo, E., Figols, J., Leno, C., Berciano, J. Ann. Neurol. (1991) [Pubmed]
  2. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Gilman, S., Koeppe, R.A., Junck, L., Kluin, K.J., Lohman, M., St Laurent, R.T. Ann. Neurol. (1994) [Pubmed]
  3. Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone. Salazar-Grueso, E.F., Rosenberg, R.S., Roos, R.P. Ann. Neurol. (1988) [Pubmed]
  4. Comparison of oculomotor findings in the progressive ataxia syndromes. Moschner, C., Perlman, S., Baloh, R.W. Brain (1994) [Pubmed]
  5. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Stefanova, N., Reindl, M., Neumann, M., Haass, C., Poewe, W., Kahle, P.J., Wenning, G.K. Am. J. Pathol. (2005) [Pubmed]
  6. Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Rosenberg, R.N., Nyhan, W.L., Bay, C., Shore, P. Neurology (1976) [Pubmed]
  7. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. Rosengren, L.E., Karlsson, J.E., Karlsson, J.O., Persson, L.I., Wikkelsø, C. J. Neurochem. (1996) [Pubmed]
  8. Glutamate and GABA levels in CSF from patients affected by dementia and olivo-ponto-cerebellar atrophy. Tosca, P., Canevari, L., Di Paolo, E., Ferrari, R., Verzé, S., Zerbi, F., Dagani, F. Acta neurologica Scandinavica. (1992) [Pubmed]
  9. Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder. Plaitakis, A., Berl, S., Yahr, M.D. Science (1982) [Pubmed]
  10. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Gilman, S., Frey, K.A., Koeppe, R.A., Junck, L., Little, R., Vander Borght, T.M., Lohman, M., Martorello, S., Lee, L.C., Jewett, D.M., Kilbourn, M.R. Ann. Neurol. (1996) [Pubmed]
  11. Brain amino acid reductions in one family with chromosome 6p-linked dominantly inherited olivopontocerebellar atrophy. Kish, S.J., Robitaille, Y., el-Awar, M., Gilbert, J., Deck, J., Chang, L.J., Schut, L. Ann. Neurol. (1991) [Pubmed]
  12. Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. Kish, S.J., Du, F., Parks, D.A., Robitaille, Y., Ball, M.J., Schut, L., Hornykiewicz, O., Schwarcz, R. Ann. Neurol. (1991) [Pubmed]
  13. Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy. Sorbi, S., Tonini, S., Giannini, E., Piacentini, S., Marini, P., Amaducci, L. Ann. Neurol. (1986) [Pubmed]
  14. Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Grossman, A., Rosenberg, R.N., Warmoth, L. Neurology (1987) [Pubmed]
  15. Lipoprotein disorder, cirrhosis, and olivopontocerebellar degeneration in two siblings. Agamanolis, D.P., Potter, J.L., Naito, H.K., Robinson, H.B., Kulasekaran, T. Neurology (1986) [Pubmed]
  16. Reduction of noradrenaline in cerebellum of patients with olivopontocerebellar atrophy. Kish, S.J., Shannak, K.S., Hornykiewicz, O. J. Neurochem. (1984) [Pubmed]
  17. Synapses in the hereditary ataxias. Koeppen, A.H., Dickson, A.C., Lamarche, J.B., Robitaille, Y. J. Neuropathol. Exp. Neurol. (1999) [Pubmed]
  18. The hereditary ataxias. Koeppen, A.H. J. Neuropathol. Exp. Neurol. (1998) [Pubmed]
  19. Quantitative autoradiographic study of L-glutamate binding sites in normal and atrophic human cerebellum. Hatziefthimiou, A., Mitsacos, A., Mitsaki, E., Plaitakis, A., Kouvelas, E.D. J. Neurosci. Res. (1991) [Pubmed]
  20. Multiple system atrophy following chronic carbon disulfide exposure. Frumkin, H. Environ. Health Perspect. (1998) [Pubmed]
  21. L-glutamate binding sites of normal and atrophic human cerebellum. Tsiotos, P., Plaitakis, A., Mitsacos, A., Voukelatou, G., Michalodimitrakis, M., Kouvelas, E.D. Brain Res. (1989) [Pubmed]
  22. Benzodiazepine receptor binding in cerebellar cortex: observations in olivopontocerebellar atrophy. Kish, S.J., Perry, T.L., Hornykiewicz, O. J. Neurochem. (1984) [Pubmed]
  23. Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease. Barbiroli, B., Martinelli, P., Patuelli, A., Lodi, R., Iotti, S., Cortelli, P., Montagna, P. Mov. Disord. (1999) [Pubmed]
  24. Myoadenylate deaminase deficiency in twins with recessive olivopontocerebellar atrophy. Uziel, G., Cornelio, F., Gellera, C., Perego, C., Rimoldi, M., DiDonato, S. Italian journal of neurological sciences. (1986) [Pubmed]
  25. Decreased insulin-like growth factor I-mediated protein tyrosine phosphorylation in human olivopontocerebellar atrophy and lurcher mutant mouse. Vig, P.J., Desaiah, D., Joshi, P., Subramony, S.H., Fratkin, J.D., Currier, R.D. J. Neurol. Sci. (1994) [Pubmed]
  26. Decrease in cerebellin and corticotropin-releasing hormone in the cerebellum of olivopontocerebellar atrophy and Shy-Drager syndrome. Mizuno, Y., Takahashi, K., Totsune, K., Ohneda, M., Konno, H., Murakami, O., Satoh, F., Sone, M., Takase, S., Itoyama, Y. Brain Res. (1995) [Pubmed]
  27. The pathogenesis of spinocerebellar ataxia. Koeppen, A.H. Cerebellum (2005) [Pubmed]
  28. Oral glutamate loading in disorders with spinocerebellar and extrapyramidal involvement: effect on plasma glutamate, aspartate and taurine. Plaitakis, A., Berl, S. J. Neural Transm. Suppl. (1983) [Pubmed]
  29. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Zhong, X.H., Haycock, J.W., Shannak, K., Robitaille, Y., Fratkin, J., Koeppen, A.H., Hornykiewicz, O., Kish, S.J. Mov. Disord. (1995) [Pubmed]
  30. Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: studied with [(123)I]beta-CIT and SPECT. Kim, G.M., Kim, S.E., Lee, W.Y. Eur. Neurol. (2000) [Pubmed]
WikiGenes - Universities